Back to 
Baker Bros. Advisors LP
Baker Bros. Advisors LP
HALO
Showing 0 of 4 quarters
Position history for Baker Bros. Advisors LP's holdings in Halozyme Therapeutics, Inc.
No. Baker Bros. Advisors exited its HALO (Halozyme Therapeutics) position in Q4 2019. Its Q3 2019 13F listed 299,969 shares worth $4.7M. Baker Bros. Advisors already held HALO in its Q1 2019 13F, the earliest on record, and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.